Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
WPH.BK
HoldUnloved QualityWattanapat Hospital Trang Public Company Limited · Healthcare · Thailand · $138M · Avg Vol: $135K/d
COMPANY DESCRIPTION
Wattanapat Hospital Trang Public Company Limited, together with its subsidiaries, provides medical services in Thailand.
FINANCIAL SUMMARY (THB)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1.1B | 1.5B | 2.0B | 2.3B | 26.7% | 2.4B |
| EPS (THB) | 0.18 | 0.14 | 0.40 | 0.50 | 41.7% | 0.48 |
| Shares | 649.2M | 649.2M | 714.1M | 714.1M | +10.0% | 714.1M |
| Debt | 897.4M | 1.2B | 929.8M | 1.2B | 11.1% | 1.3B |
| Equity | 1.0B | 1.1B | 1.6B | 1.9B | 23.0% | — |
| Op CF | 408.4M | 277.3M | 476.4M | 535.2M | 9.4% | 594.7M |
| Inv CF | -526.2M | -470.3M | -362.3M | -803.0M | — | — |
| Fin CF | 117.8M | 230.6M | -124.9M | 332.2M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of WPH.BK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| WPH.BK | Wattanapat Hospital Trang Public Company Limited(you) | $138M | 60 | Hold |
| CMR.BK | Chiang Mai Ram Medical Business Public Company Limited | $161M | 67 | Buy |
| TNH.BK | Thai Nakarin Hospital Public Company Limited | $156M | 79 | Buy |
| EKH.BK | Ekachai Medical Care Public Company Limited | $127M | 88 | Strong Buy |
| RAM.BK | Ramkhamhaeng Hospital Public Company Limited | $643M | 61 | Hold |
| RJH.BK | Rajthanee Hospital Public Company Limited | $135M | 95 | Strong Buy |
| NTV.BK | Nonthavej Hospital Public Company Limited | $93M | 89 | Strong Buy |
| THG.BK | Thonburi Healthcare Group Public Company Limited | $406M | 44 | Hold |
| VIBHA.BK | Vibhavadi Medical Center Public Company Limited | $554M | 71 | Buy |
| RPH.BK | Ratchaphruek Hospital Public Company Limited | $79M | 89 | Strong Buy |
Peer medians: ROE 12.0% · P/E 15.4x · Gross margin 27.9%